Economic Evaluation of Treatment With Trastuzumab Deruxtecan for HER2-Low Advanced or Metastatic Breast Cancer in Previously Treated Patients

Colaboración

Año: 2025

Fenix-Caballero, S; Caleffa-Menendez, P; Dominguez-Santana, CM; Alegre-Del-Rey, EJ; Lima, AOD

Título: PHARMACOECONOMICS-OPEN

• Q2